BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18618425)

  • 21. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
    Wahed AS; Tsiatis AA
    Biometrics; 2004 Mar; 60(1):124-33. PubMed ID: 15032782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of clustered matched-pair data.
    Durkalski VL; Palesch YY; Lipsitz SR; Rust PF
    Stat Med; 2003 Aug; 22(15):2417-28. PubMed ID: 12872299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical design of quantitative mass spectrometry-based proteomic experiments.
    Oberg AL; Vitek O
    J Proteome Res; 2009 May; 8(5):2144-56. PubMed ID: 19222236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Methods Med Res; 2008 Aug; 17(4):439-58. PubMed ID: 17698940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased power to detect gene-environment interaction using siblings controls.
    Andrieu N; Dondon MG; Goldstein AM
    Ann Epidemiol; 2005 Oct; 15(9):705-11. PubMed ID: 16157257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the effect of treatment in experiments with correlated binary outcomes.
    Zucker D; Wittes J
    Biometrics; 1992 Sep; 48(3):695-709. PubMed ID: 1420835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Wilcoxon signed rank test for paired comparisons of clustered data.
    Rosner B; Glynn RJ; Lee ML
    Biometrics; 2006 Mar; 62(1):185-92. PubMed ID: 16542245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothesis testing in functional linear regression models with Neyman's truncation and wavelet thresholding for longitudinal data.
    Yang X; Nie K
    Stat Med; 2008 Mar; 27(6):845-63. PubMed ID: 17610294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A powerful and robust test statistic for randomization inference in group-randomized trials with matched pairs of groups.
    Zhang K; Traskin M; Small DS
    Biometrics; 2012 Mar; 68(1):75-84. PubMed ID: 21732926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A SAS macro for constrained randomization of group-randomized designs.
    Chaudhary MA; Moulton LH
    Comput Methods Programs Biomed; 2006 Sep; 83(3):205-10. PubMed ID: 16870302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Various randomized designs can be used to evaluate medical tests.
    Lijmer JG; Bossuyt PM
    J Clin Epidemiol; 2009 Apr; 62(4):364-73. PubMed ID: 18945590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A methodology for analysing a repeated measures and survival outcome simultaneously.
    Rochon J; Gillespie BW
    Stat Med; 2001 Apr; 20(8):1173-84. PubMed ID: 11304734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
    Rubin DB
    Stat Med; 2007 Jan; 26(1):20-36. PubMed ID: 17072897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic association analysis using discordant-relative-pairs.
    Yan T; Yang YN; Cheng X; DeAngelis MM; Hoh J; Zhang H
    Ann Hum Genet; 2009 Jan; 73(1):84-94. PubMed ID: 19040657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developments in cluster randomized trials and Statistics in Medicine.
    Campbell MJ; Donner A; Klar N
    Stat Med; 2007 Jan; 26(1):2-19. PubMed ID: 17136746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.